All Insights White Paper Global Pharma Pricing And Market Effects Of President Trump’s Proposed Policies

    Global Pharma Pricing And Market Effects Of President Trump’s Proposed Policies

    Industry Insights

    Global Pharma Pricing And Market Effects Of President Trump’s Proposed Policies

    President Trump has targeted the pharma industry for policy attention as noted in this white paper series (see two articles on President Trump and his potential policy effects available through the Axtria Research Hub).

    Download White Paper
    Global Pharma Pricing And Market Effects Of President Trump’s Proposed Policies

    President Trump campaigned to use the buying power of the federal government to directly negotiate downward the prices of drugs used by Medicare patients. The question this white paper addresses is what could this policy, if enacted, have on the structure of US and global drug pricing and associated market effects? Specific projected effects are highlighted for both the US and global pharma markets. The paper concludes by noting what pharma companies and government policymakers must do to counteract the expected adverse consequences of President Trump’s policies. The failure of government policymakers to appropriately respond to Trump’s pricing policies will result in a pharma industry that is less dynamic in its ability to develop and launch innovative medicines that benefit the global healthcare community.

    Dr. George A. Chressanthis is currently Principal Scientist at Axtria. He brings a unique combination of professional experiences into the analysis of strategic and operational issues affecting the biopharmaceutical industry.

    Contact us at insights@axtria.com with any questions.

    Complete the brief form to download the white paper

    Recommended insights

    Pharma Pricing And Market Effects White Paper

    Blog

    Three Data Analytics Opportunities In Animal Health To Watch Out For

    Pharma Pricing And Market Effects White Paper

    White Paper

    Do Pharma Companies Need To Rethink Their Sales Operations Design?

    Pharma Pricing And Market Effects White Paper

    White Paper

    Effects Of A Resurgence In COVID-19 Cases On Future Pharmaceutical Business Planning